Menu
GWAS Study

Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women.

Kadalayil L, Khan S, Nevanlinna H et al.

29158497 PubMed ID
GWAS Study Type
6042 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KL
Kadalayil L
KS
Khan S
NH
Nevanlinna H
FP
Fasching PA
CF
Couch FJ
HJ
Hopper JL
LJ
Liu J
MT
Maishman T
DL
Durcan L
GS
Gerty S
BC
Blomqvist C
RB
Rack B
JW
Janni W
CA
Collins A
ED
Eccles D
TW
Tapper W
Chapter II

Abstract

Summary of the research findings

To identify genetic variants associated with breast cancer prognosis we conduct a meta-analysis of overall survival (OS) and disease-free survival (DFS) in 6042 patients from four cohorts. In young women, breast cancer is characterized by a higher incidence of adverse pathological features, unique gene expression profiles and worse survival, which may relate to germline variation. To explore this hypothesis, we also perform survival analysis in 2315 patients aged ≤ 40 years at diagnosis. Here, we identify two SNPs associated with early-onset DFS, rs715212 (P meta = 3.54 × 10-5) and rs10963755 (P meta = 3.91 × 10-4) in ADAMTSL1. The effect of these SNPs is independent of classical prognostic factors and there is no heterogeneity between cohorts. Most importantly, the association with rs715212 is noteworthy (FPRP <0.2) and approaches genome-wide significance in multivariable analysis (P multivariable = 5.37 × 10-8). Expression quantitative trait analysis provides tentative evidence that rs715212 may influence AREG expression (P eQTL = 0.035), although further functional studies are needed to confirm this association and determine a mechanism.

4,739 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

6042
Total Participants
GWAS
Study Type
Yes
Replicated
1,301 European ancestry individuals, 2 South African individuals
Replication Participants
European
Ancestry
U.K., Australia, Germany, Finland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.